Global Rivaroxaban Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Publisher Name :
Date: 15-Mar-2019
No. of pages: 101

Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8-12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.

Scope of the Report:

The global average price of Rivaroxaban is in the decreasing trend, from 5.62 USD/Unit in 2011 to 5.34 USD/Unit in 2015. With the situation of global economy, prices will be in slowly decreasing trend in the following five years.

Bayer is the only supplier of Rivaroxaban enjoying production market share100% in 2015 and it will still in this situation until 2023.

The worldwide market for Rivaroxaban is expected to grow at a CAGR of roughly 9.4% over the next five years, will reach 10100 million US$ in 2024, from 5860 million US$ in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Rivaroxaban in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

- Bayer

- J&J

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- 2.5 mg

- 10 mg

- 15 mg

- 20 mg

Market Segment by Applications, can be divided into

- Acute Coronary Syndrome (ACS)

- Venous Thromboembolism (VTE)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Rivaroxaban product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Rivaroxaban, with price, sales, revenue and global market share of Rivaroxaban in 2017 and 2018.

Chapter 3, the Rivaroxaban competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Rivaroxaban breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Rivaroxaban market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Rivaroxaban sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global Rivaroxaban Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview
1.1 Rivaroxaban Introduction
1.2 Market Analysis by Type
1.2.1 2.5 mg
1.2.2 10 mg
1.2.3 15 mg
1.2.4 20 mg
1.3 Market Analysis by Applications
1.3.1 Acute Coronary Syndrome (ACS)
1.3.2 Venous Thromboembolism (VTE)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Rivaroxaban Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Rivaroxaban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 J&J
2.2.1 Business Overview
2.2.2 Rivaroxaban Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 J&J Rivaroxaban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Rivaroxaban Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Rivaroxaban Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Rivaroxaban Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Rivaroxaban Manufacturer Market Share in 2018
3.3.2 Top 6 Rivaroxaban Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Rivaroxaban Market Analysis by Regions
4.1 Global Rivaroxaban Sales, Revenue and Market Share by Regions
4.1.1 Global Rivaroxaban Sales and Market Share by Regions (2014-2019)
4.1.2 Global Rivaroxaban Revenue and Market Share by Regions (2014-2019)
4.2 North America Rivaroxaban Sales and Growth Rate (2014-2019)
4.3 Europe Rivaroxaban Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Rivaroxaban Sales and Growth Rate (2014-2019)
4.5 South America Rivaroxaban Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Rivaroxaban Sales and Growth Rate (2014-2019)
5 North America Rivaroxaban by Country
5.1 North America Rivaroxaban Sales, Revenue and Market Share by Country
5.1.1 North America Rivaroxaban Sales and Market Share by Country (2014-2019)
5.1.2 North America Rivaroxaban Revenue and Market Share by Country (2014-2019)
5.2 United States Rivaroxaban Sales and Growth Rate (2014-2019)
5.3 Canada Rivaroxaban Sales and Growth Rate (2014-2019)
5.4 Mexico Rivaroxaban Sales and Growth Rate (2014-2019)
6 Europe Rivaroxaban by Country
6.1 Europe Rivaroxaban Sales, Revenue and Market Share by Country
6.1.1 Europe Rivaroxaban Sales and Market Share by Country (2014-2019)
6.1.2 Europe Rivaroxaban Revenue and Market Share by Country (2014-2019)
6.2 Germany Rivaroxaban Sales and Growth Rate (2014-2019)
6.3 UK Rivaroxaban Sales and Growth Rate (2014-2019)
6.4 France Rivaroxaban Sales and Growth Rate (2014-2019)
6.5 Russia Rivaroxaban Sales and Growth Rate (2014-2019)
6.6 Italy Rivaroxaban Sales and Growth Rate (2014-2019)
7 Asia-Pacific Rivaroxaban by Country
7.1 Asia-Pacific Rivaroxaban Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Rivaroxaban Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Rivaroxaban Revenue and Market Share by Country (2014-2019)
7.2 China Rivaroxaban Sales and Growth Rate (2014-2019)
7.3 Japan Rivaroxaban Sales and Growth Rate (2014-2019)
7.4 Korea Rivaroxaban Sales and Growth Rate (2014-2019)
7.5 India Rivaroxaban Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Rivaroxaban Sales and Growth Rate (2014-2019)
8 South America Rivaroxaban by Country
8.1 South America Rivaroxaban Sales, Revenue and Market Share by Country
8.1.1 South America Rivaroxaban Sales and Market Share by Country (2014-2019)
8.1.2 South America Rivaroxaban Revenue and Market Share by Country (2014-2019)
8.2 Brazil Rivaroxaban Sales and Growth Rate (2014-2019)
8.3 Argentina Rivaroxaban Sales and Growth Rate (2014-2019)
8.4 Colombia Rivaroxaban Sales and Growth Rate (2014-2019)
9 Middle East and Africa Rivaroxaban by Countries
9.1 Middle East and Africa Rivaroxaban Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Rivaroxaban Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Rivaroxaban Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Rivaroxaban Sales and Growth Rate (2014-2019)
9.3 Turkey Rivaroxaban Sales and Growth Rate (2014-2019)
9.4 Egypt Rivaroxaban Sales and Growth Rate (2014-2019)
9.5 Nigeria Rivaroxaban Sales and Growth Rate (2014-2019)
9.6 South Africa Rivaroxaban Sales and Growth Rate (2014-2019)
10 Global Rivaroxaban Market Segment by Type
10.1 Global Rivaroxaban Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Rivaroxaban Sales and Market Share by Type (2014-2019)
10.1.2 Global Rivaroxaban Revenue and Market Share by Type (2014-2019)
10.2 2.5 mg Sales Growth and Price
10.2.1 Global 2.5 mg Sales Growth (2014-2019)
10.2.2 Global 2.5 mg Price (2014-2019)
10.3 10 mg Sales Growth and Price
10.3.1 Global 10 mg Sales Growth (2014-2019)
10.3.2 Global 10 mg Price (2014-2019)
10.4 15 mg Sales Growth and Price
10.4.1 Global 15 mg Sales Growth (2014-2019)
10.4.2 Global 15 mg Price (2014-2019)
10.5 20 mg Sales Growth and Price
10.5.1 Global 20 mg Sales Growth (2014-2019)
10.5.2 Global 20 mg Price (2014-2019)
11 Global Rivaroxaban Market Segment by Application
11.1 Global Rivaroxaban Sales Market Share by Application (2014-2019)
11.2 Acute Coronary Syndrome (ACS) Sales Growth (2014-2019)
11.3 Venous Thromboembolism (VTE) Sales Growth (2014-2019)
12 Rivaroxaban Market Forecast (2019-2024)
12.1 Global Rivaroxaban Sales, Revenue and Growth Rate (2019-2024)
12.2 Rivaroxaban Market Forecast by Regions (2019-2024)
12.2.1 North America Rivaroxaban Market Forecast (2019-2024)
12.2.2 Europe Rivaroxaban Market Forecast (2019-2024)
12.2.3 Asia-Pacific Rivaroxaban Market Forecast (2019-2024)
12.2.4 South America Rivaroxaban Market Forecast (2019-2024)
12.2.5 Middle East and Africa Rivaroxaban Market Forecast (2019-2024)
12.3 Rivaroxaban Market Forecast by Type (2019-2024)
12.3.1 Global Rivaroxaban Sales Forecast by Type (2019-2024)
12.3.2 Global Rivaroxaban Market Share Forecast by Type (2019-2024)
12.4 Rivaroxaban Market Forecast by Application (2019-2024)
12.4.1 Global Rivaroxaban Sales Forecast by Application (2019-2024)
12.4.2 Global Rivaroxaban Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Rivaroxaban Picture
Table Product Specifications of Rivaroxaban
Figure Global Sales Market Share of Rivaroxaban by Types in 2018
Table Rivaroxaban Types for Major Manufacturers
Figure 2.5 mg Picture
Figure 10 mg Picture
Figure 15 mg Picture
Figure 20 mg Picture
Figure Rivaroxaban Sales Market Share by Applications in 2018
Figure Acute Coronary Syndrome (ACS) Picture
Figure Venous Thromboembolism (VTE) Picture
Figure United States Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Figure France Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Figure UK Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Figure China Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Figure India Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Rivaroxaban Revenue (Value) and Growth Rate (2014-2024)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Rivaroxaban Type and Applications
Table Bayer Rivaroxaban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table J&J Basic Information, Manufacturing Base and Competitors
Table J&J Rivaroxaban Type and Applications
Table J&J Rivaroxaban Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Rivaroxaban Sales by Manufacturer (2017-2018)
Figure Global Rivaroxaban Sales Market Share by Manufacturer in 2017
Figure Global Rivaroxaban Sales Market Share by Manufacturer in 2018
Table Global Rivaroxaban Revenue by Manufacturer (2017-2018)
Figure Global Rivaroxaban Revenue Market Share by Manufacturer in 2017
Figure Global Rivaroxaban Revenue Market Share by Manufacturer in 2018
Figure Top 3 Rivaroxaban Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Rivaroxaban Manufacturer (Revenue) Market Share in 2018
Figure Global Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Global Rivaroxaban Revenue and Growth Rate (2014-2019)
Table Global Rivaroxaban Sales by Regions (2014-2019)
Table Global Rivaroxaban Sales Market Share by Regions (2014-2019)
Table Global Rivaroxaban Revenue by Regions (2014-2019)
Figure Global Rivaroxaban Revenue Market Share by Regions in 2014
Figure Global Rivaroxaban Revenue Market Share by Regions in 2018
Figure North America Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Europe Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Rivaroxaban Sales and Growth Rate (2014-2019)
Figure South America Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Rivaroxaban Sales and Growth Rate (2014-2019)
Figure North America Rivaroxaban Revenue and Growth Rate (2014-2019)
Table North America Rivaroxaban Sales by Countries (2014-2019)
Table North America Rivaroxaban Sales Market Share by Countries (2014-2019)
Figure North America Rivaroxaban Sales Market Share by Countries in 2014
Figure North America Rivaroxaban Sales Market Share by Countries in 2018
Table North America Rivaroxaban Revenue by Countries (2014-2019)
Table North America Rivaroxaban Revenue Market Share by Countries (2014-2019)
Figure North America Rivaroxaban Revenue Market Share by Countries in 2014
Figure North America Rivaroxaban Revenue Market Share by Countries in 2018
Figure United States Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Canada Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Mexico Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Europe Rivaroxaban Revenue and Growth Rate (2014-2019)
Table Europe Rivaroxaban Sales by Countries (2014-2019)
Table Europe Rivaroxaban Sales Market Share by Countries (2014-2019)
Table Europe Rivaroxaban Revenue by Countries (2014-2019)
Figure Europe Rivaroxaban Revenue Market Share by Countries in 2017
Figure Europe Rivaroxaban Revenue Market Share by Countries in 2018
Figure Germany Rivaroxaban Sales and Growth Rate (2014-2019)
Figure UK Rivaroxaban Sales and Growth Rate (2014-2019)
Figure France Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Russia Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Italy Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Rivaroxaban Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Rivaroxaban Sales by Countries (2014-2019)
Table Asia-Pacific Rivaroxaban Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Rivaroxaban Sales Market Share by Countries 2018
Table Asia-Pacific Rivaroxaban Revenue by Countries (2014-2019)
Figure Asia-Pacific Rivaroxaban Revenue Market Share by Countries 2018
Figure China Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Japan Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Korea Rivaroxaban Sales and Growth Rate (2014-2019)
Figure India Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Southeast Asia Rivaroxaban Sales and Growth Rate (2014-2019)
Figure South America Rivaroxaban Revenue and Growth Rate (2014-2019)
Table South America Rivaroxaban Sales by Countries (2014-2019)
Table South America Rivaroxaban Sales Market Share by Countries (2014-2019)
Figure South America Rivaroxaban Sales Market Share by Countries in 2018
Table South America Rivaroxaban Revenue by Countries (2014-2019)
Table South America Rivaroxaban Revenue Market Share by Countries (2014-2019)
Figure South America Rivaroxaban Revenue Market Share by Countries in 2018
Figure Brazil Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Argentina Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Colombia Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Rivaroxaban Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Rivaroxaban Sales by Countries (2014-2019)
Table Middle East and Africa Rivaroxaban Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Rivaroxaban Sales Market Share by Countries in 2018
Table Middle East and Africa Rivaroxaban Revenue by Countries (2014-2019)
Table Middle East and Africa Rivaroxaban Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Rivaroxaban Revenue Market Share by Countries in 2014
Figure Middle East and Africa Rivaroxaban Revenue Market Share by Countries in 2018
Figure Saudi Arabia Rivaroxaban Sales and Growth Rate (2014-2019)
Figure UAE Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Egypt Rivaroxaban Sales and Growth Rate (2014-2019)
Figure Nigeria Rivaroxaban Sales and Growth Rate (2014-2019)
Figure South Africa Rivaroxaban Sales and Growth Rate (2014-2019)
Table Global Rivaroxaban Sales by Type (2014-2019)
Table Global Rivaroxaban Sales Share by Type (2014-2019)
Table Global Rivaroxaban Revenue by Type (2014-2019)
Table Global Rivaroxaban Revenue Share by Type (2014-2019)
Figure Global 2.5 mg Sales Growth (2014-2019)
Figure Global 2.5 mg Price (2014-2019)
Figure Global 10 mg Sales Growth (2014-2019)
Figure Global 10 mg Price (2014-2019)
Figure Global 15 mg Sales Growth (2014-2019)
Figure Global 15 mg Price (2014-2019)
Figure Global 20 mg Sales Growth (2014-2019)
Figure Global 20 mg Price (2014-2019)
Table Global Rivaroxaban Sales by Application (2014-2019)
Table Global Rivaroxaban Sales Share by Application (2014-2019)
Figure Global Venous Thromboembolism (VTE) Sales Growth (2014-2019)
Figure Global Rivaroxaban Sales, Revenue and Growth Rate (2019-2024)
Table Global Rivaroxaban Sales Forecast by Regions (2019-2024)
Table Global Rivaroxaban Market Share Forecast by Regions (2019-2024)
Figure North America Sales Rivaroxaban Market Forecast (2019-2024)
Figure Europe Sales Rivaroxaban Market Forecast (2019-2024)
Figure Asia-Pacific Sales Rivaroxaban Market Forecast (2019-2024)
Figure South America Sales Rivaroxaban Market Forecast (2019-2024)
Figure Middle East and Africa Sales Rivaroxaban Market Forecast (2019-2024)
Table Global Rivaroxaban Sales Forecast by Type (2019-2024)
Table Global Rivaroxaban Market Share Forecast by Type (2019-2024)
Table Global Rivaroxaban Sales Forecast by Application (2019-2024)
Table Global Rivaroxaban Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
  • Global (United States, European Union and China) Retinal Drugs Market Research Report 2019-2025
    Published: 16-Aug-2019        Price: US 3280 Onwards        Pages: 117
    Retinal drugs are the medications that are used for the treatment of retinal diseases North America dominated the global retinal drugs market in 2017 In 2019, the market size of Retinal Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as......
  • Global (United States, European Union and China) Nalbuphine HCL Market Research Report 2019-2025
    Published: 15-Aug-2019        Price: US 3280 Onwards        Pages: 118
    Nalbuphine HCL (Nalbuphine hydrochloride) is a narcotic pain reliever used to treat moderate to severe pain.Nubain is also used for treating pain just after surgery or childbirth. In 2019, the market size of Nalbuphine HCL is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 201......
  • Global and China Epinephrine Market Research by Company, Type & Application 2013-2025
    Published: 15-Aug-2019        Price: US 2000 Onwards        Pages: 73
    Summary Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated e......
  • Global (United States, European Union and China) Bioengineered Protein Drugs Market Research Report 2019-2025
    Published: 14-Aug-2019        Price: US 3280 Onwards        Pages: 117
    Bioengineered proteins are designed as the fundamental participants in all biological processes, represent as powerful therapeutic agents and include a broad range of products such as growth factors, hormones, vaccines, monoclonal antibodies, cytokines and few others. These special drugs are gaining attention across pharmaceutical industries due to their specificity, safety, bioreactivity and success rate in treating life-threatening diseases and injuries. In 2019, the market size of Bio......
  • Global and China Inhalation & Nasal Spray Generic Drugs Market Research by Company, Type & Application 2013-2025
    Published: 14-Aug-2019        Price: US 2000 Onwards        Pages: 74
    Summary Generic drugs are drugs that are not associated with any company or a brand name and are subject to regulation of countries where they are dispensed. According to US FDA, A generic drug is identical--or bioequivalent--to a brand name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.Inhalation & Nasal Spray is a kind of drug used to relieve sneezing, runny, stuffy, or itchy nose and itchy, watery eyes caus......
  • Global and China Fosfomycin Trometamol Market Research by Company, Type & Application 2013-2025
    Published: 14-Aug-2019        Price: US 2000 Onwards        Pages: 69
    Summary Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform. Mainly for the treatment of urinary tract infections such as cystitis, urethritis. Market Segment as follows: By Type - Fosfomycin Tromethamine Granules - Fosfomycin Tromethamine Powder By Application - Common Urinary Tract ......
  • Global Enoxaparin Industry Market Research Report
    Published: 13-Aug-2019        Price: US 2960 Onwards        Pages: 130
    The Enoxaparin market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Enoxaparin industrial chain, this report mainly elaborates the definition, types, applications and major players of Enoxaparin market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2019......
  • Global Lyme Disease Vaccine Industry Market Research Report
    Published: 13-Aug-2019        Price: US 2960 Onwards        Pages: 115
    The Lyme Disease Vaccine market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Lyme Disease Vaccine industrial chain, this report mainly elaborates the definition, types, applications and major players of Lyme Disease Vaccine market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, ind......
  • Global Ion Channel Modulators Industry Market Research Report
    Published: 13-Aug-2019        Price: US 2960 Onwards        Pages: 123
    The Ion Channel Modulators market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Ion Channel Modulators industrial chain, this report mainly elaborates the definition, types, applications and major players of Ion Channel Modulators market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise product......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs